BCMU
STJ

BlueCrest Capital Management (UK)’s St Jude Medical STJ Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$450K Sell
7,491
-41,270
-85% -$2.7M 0.02% 424
2014
Q2 		$3.38M Buy
+48,761
New +$3.16M 0.12% 140

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlueCrest Capital Management (UK)'s STJ Position: Q3 2014 in Review

BlueCrest Capital Management (UK) reduced its St Jude Medical (STJ) stake by 85% in Q3 2014, selling an estimated $2.7M and leaving 7,491 shares worth $450K. The position accounts for 0.02% of the portfolio, ranked #424.

BlueCrest Capital Management (UK) first reported a position in STJ in Q2 2014 and has held it in 2 quarters since. The position peaked at $3.38M in Q2 2014. 563 funds tracked by Wall St. Rank hold STJ as of Q3 2014.

  • BlueCrest Capital Management (UK) held 7,491 shares of St Jude Medical worth $450K as of Q3 2014.
  • BlueCrest Capital Management (UK) sold 41,270 St Jude Medical shares in Q3 2014, an estimated $2.7M.
  • St Jude Medical made up 0.02% of BlueCrest Capital Management (UK)'s portfolio in Q3 2014, its #424 holding.
  • BlueCrest Capital Management (UK) first reported a position in St Jude Medical in Q2 2014 and has held it in 2 quarters since.
  • BlueCrest Capital Management (UK)'s St Jude Medical position peaked at $3.38M in Q2 2014.
  • 563 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.